PO Editorial Advisory Board
Rafik H. Bishara, PhD, Technical Advisor
William Downey, President, HighTech Business Decisions
David P. Elder, PhD, Director, Scinovo Group, GlaxoSmithKline R&D
Dr. Nancy A. Gillett, Corporate Executive VP and President, Global Preclinical Services, Charles River Laboratories
C. Ray Goff, Jr., RKG Solutions, LLC
Robert A. Goodnow Jr., PhD, Discovery Chemistry, Lead Generation, Hoffmann - La Roche Inc.
Wayne Heminway, Business Development Executive, Cook Pharmica LLC
Derek Hennecke, CEO, Xcelience
Dennis Jenke, PhD, Baxter Distinguished Scientist, Technology Resources Division, Baxter Healthcare Corporation
Hemant N. Joshi, Founder, Tara Innovations LLC
Eric S. Langer, MSB, President and Managing Partner, BioPlan Associates, Inc.
Max Lazar, President, FDA Regulatory Compliance Consulting
Joseph Swaroop Mathen, PhD, Associate Director, Chemistry,
PharmaCor, Inc.
Eduardo Motti, MD, Owner, Trials & Training Consult
Daniel L. Norwood, PhD, Distinguished Research Fellow, Boehringer Ingelheim Pharmaceuticals, Inc.
Terence S. Novak, President, Commerical Operations, Norwich Pharma Services
Mark Sawicki, PhD, Chief Business Office, Cambridge Major Laboratories
Paul Skultety, PhD, Director, Pharmaceutical Development Services, Xcelience, LLC
Scott M. Wheelwright, PhD, Founder, Complya Asia Co., Ltd., Strategic Manufacturing Worldwide, Inc.
Karen Zuklie,
Director of Project Planning in Medical Research Operations, Purdue Pharma LP